SGLT2 ‐Inhibition reverts urinary peptide changes associated with severe COVID‐19: An in‐silico proof‐of‐principle of proteomics‐based drug repurposing

This article is protected by copyright. All rights reserved

Source: Proteomics - September 4, 2021 Category: Biochemistry Authors: Agnieszka Latosinska, Justyna Siwy, David Z. Cherney, Bruce A. Perkins, Harald Mischak, Joachim Beige Tags: Accelerated Article Source Type: research